Australian pharma company seeks lenient penalty in criminal cartel case
An active pharmaceutical ingredient producer has asked an Australian court to fine it less than A$1 million (€686,000) after pleading guilty to three counts of criminal cartel conduct, citing the limited impact on Australian consumers.
To read more
Subscribe to Global Competition Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.